After delivering two genes in vivo, the growth of the breast cancer lesion was significantly inhibited, indicating that the fusion of the two mechanisms induced strong apoptosis, indicating that the dinuclear acid model of a single carrier could enhance the anti-cancer ability of TRAIL. This evidence concerns the gene TNFSF10 and cancer.